(BUY 3 BOTTLES OF NMN 30000 GET 1 FREE NMN 9000) BUY 3 BOTTLES NMN 18000 OR NMN 15000 GET 1 FREE NAC 30000 LIMITED TIME ONLY OVER $99 ORDER FREE SHIPPING
for Canada, US, China & HK
(BUY 3 BOTTLES OF NMN 30000 GET 1 FREE NMN 9000) BUY 3 BOTTLES NMN 18000 OR NMN 15000 GET 1 FREE NAC 30000 LIMITED TIME ONLY OVER $99 ORDER FREE SHIPPING
for Canada, US, China & HK
Nicotinamide mononucleotide (NMN) is a substance present in all living things. It is a ribonucleotide, a crucial component of the nucleic acid RNA. NMN is a type of nicotinamide adenine dinucleotide (NAD+) precursor, which helps raise NAD+ levels in cells.
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme necessary for life and cellular processes. It functions as an assistant to enzymes, enabling them to carry out chemical reactions.
NAD+ has attracted scientific interest due to its abundance and crucial functions in the body. Studies in animals have shown positive effects of increasing NAD+ levels in metabolic and age-related conditions. It may have potential benefits for age-related illnesses like diabetes, cardiovascular disease, neurodegeneration, and immune system decline.
Our bodies produce NAD+ from precursor molecules, including L-tryptophan, nicotinamide, nicotinic acid, nicotinamide riboside, and nicotinamide mononucleotide. These precursors undergo various biochemical pathways to synthesize NAD+.
NMN is absorbed into cells through a transporter on the cell surface. It may enter cells directly, bypassing the need for conversion. NMN injections have been shown to increase NAD+ levels in various tissues. Oral administration of NMN in mice also leads to increased NAD+ levels.
Calorie restriction has been linked to improved NAD+ levels and sirtuin activity. While NAD+ is found in certain foods, it's not sufficient to significantly change cellular NAD+ levels. Supplementation with NAD+ precursors like NMN and nicotinamide riboside can boost NAD+ levels effectively.
Studies suggest that NMN is generally safe and non-toxic, even at high dosages. Human clinical trials have been conducted, demonstrating its safety in single doses. However, long-term safety and effectiveness require further investigation.
In 1906, Arthur Harden and William John Young discovered a “factor” in brewer’s yeast that enhanced fermentation. This factor turned out to be NAD. In 1929, Harden and Hans von Euler-Chelpin received the Nobel Prize for their research on NAD’s chemical properties.
During the 1930s, Otto Warburg identified NAD’s essential role in numerous biochemical processes. NAD facilitates the transfer of electrons, providing the energy required for biological activities.
In 1937, Conrad Elvehjem and his colleagues discovered that NAD+ supplementation cured pellagra, a disease caused by a niacin deficiency. This finding led to the use of nicotinamide, an NMN precursor, for pellagra treatment.
Arthur Kornberg’s work in the 1940s and 1950s revealed the principles behind DNA replication and RNA transcription, both essential processes for life. NAD+ played a significant role in these processes.
In the same year, Chambon, Weill, and Mandel discovered that nicotinamide mononucleotide (NMN) activates an important nuclear enzyme. This discovery led to further exploration of PARPs and their involvement in DNA damage repair and cellular processes.
In 1976, Rechsteiner and colleagues found evidence suggesting that NAD+ had additional essential functions in mammalian cells beyond energy transfer. This led to the discovery that sirtuins use NAD to regulate gene expression and potentially extend lifespan.
Since then, there has been growing interest in NAD and its metabolites, such as NMN and NR, for their potential anti-aging properties. Research has focused on understanding their effects on lifespan and age-related conditions.